What to Expect in Month 3 Nausea improvement: Drops from constant/frequent to occasional/rare for most patients Energy returns: As your body adjusts to new eating patterns and medication Appetite normalization: Still suppressed (therapeutic effect) but more predictable Weight loss becomes visible: Average 8-10% by week 12, friends and family notice Confidence builds: Youve survived the worst, know you can continue 4 Strategies for Month 3 11
Comments on association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes
Why it matters: A different mechanism can create research interest without proving approval, superiority, or suitability
Fat cells are biologically active little factories, and they pump out a steady stream of inflammatory molecules IL-6, TNF-alpha, and IL-1
GLP-1 Supplement Reviews I have seen an increase in advertisements for GLP-1 boosting supplements on social media
So those approved titration schedules are the evidence-based doses, he says